Steinar Johan Engelsen
Vorstandsvorsitzender bei Engelsen Invest AS
Aktive Positionen von Steinar Johan Engelsen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Teknoinvest AS
Teknoinvest AS Investment ManagersFinance Teknoinvest AS (Teknoinvest) is a venture capital firm headquartered in Oslo, Norway, with offices in New York, and Stockholm, Sweden. The firm was founded in 1984 by Bjørn Bjorå. | Private Equity Investor | 01.01.1996 | - |
Engelsen Invest AS
Engelsen Invest AS Financial ConglomeratesFinance Engelsen Invest AS operates as a venture capital firm. It engages in portfolio investment services. The firm provides investment services such as investment trusts. The company was founded on June 15, 2001 and is headquartered in Stabekk, Norway. | Vorstandsvorsitzender | 17.06.2011 | - |
Vorsitzender | 17.06.2011 | - |
Karriereverlauf von Steinar Johan Engelsen
Ehemalige bekannte Positionen von Steinar Johan Engelsen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
INSMED INCORPORATED | Direktor/Vorstandsmitglied | 29.11.1999 | 11.05.2022 |
Independent Dir/Board Member | 29.11.1999 | 11.05.2022 | |
SOLENO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 20.04.2004 | 31.12.2017 |
Independent Dir/Board Member | 20.04.2004 | 31.12.2017 | |
Affitech AS /Old/
Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Affitech AS discovers and develops human therapeutic antibodies. It focuses on molecule and cell based antibody discovery. The company was founded by Martin Welschof, Ole Jorgen Marvik, and Michael Braunagel in 1997 and is headquartered in Oslo, Norway. | Direktor/Vorstandsmitglied | - | 16.06.2009 |
Angiogenix, Inc.
Angiogenix, Inc. Pharmaceuticals: MajorHealth Technology Angiogenix, Inc. develops therapeutic solutions for chronic vascular disease. Its products help the body produce new blood vessels to increase blood flow. The company's product ACCLAIM treats chronic ischemia (lack of oxygen in the heart muscle). Angx1039 is being developed to treat peripheral vascular disease (a narrowing of the vessels carrying blood to the legs, arms and internal organs) and Angx3227 targets sickle cell disease (an inherited disorder that affects the shape of red blood cells). Its fourth product, Vasotrophin increases blood vessel density. The company is headquartered at Burlingame, CA | Direktor/Vorstandsmitglied | - | 06.03.2008 |
Centaur Pharmaceuticals, Inc. | Vorstandsvorsitzender | 01.01.2000 | 01.11.2000 |
INSMED Pharmaceuticals, Inc.
INSMED Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology INSMED Pharmaceuticals, Inc. develops products for the diagnosis and treatment of conditions associated with insulin resistance. The company is headquartered in Richmond, VA. | Direktor/Vorstandsmitglied | 01.01.1998 | 01.01.2000 |
Nycomed Pharma Holding A/S
Nycomed Pharma Holding A/S Pharmaceuticals: GenericHealth Technology Nycomed Pharma Holding A/S operates as a holding company with an interest in manufacturing generic drugs. It is active in therapeutic areas, such as cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. The company develops, manufactures, and markets products through Nycomed Pharma A/S. Nycomed Pharma Holding is headquartered in Roskilde, Denmark. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1994 | 01.10.1996 |
░░░░░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Steinar Johan Engelsen
University of Oslo | Doctorate Degree |
Statistik
International
Norwegen | 8 |
Vereinigte Staaten | 6 |
Dänemark | 2 |
Operativ
Director/Board Member | 6 |
Chief Tech/Sci/R&D Officer | 3 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 9 |
Finance | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
INSMED INCORPORATED | Health Technology |
SOLENO THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 10 |
---|---|
Teknoinvest AS
Teknoinvest AS Investment ManagersFinance Teknoinvest AS (Teknoinvest) is a venture capital firm headquartered in Oslo, Norway, with offices in New York, and Stockholm, Sweden. The firm was founded in 1984 by Bjørn Bjorå. | Finance |
Angiogenix, Inc.
Angiogenix, Inc. Pharmaceuticals: MajorHealth Technology Angiogenix, Inc. develops therapeutic solutions for chronic vascular disease. Its products help the body produce new blood vessels to increase blood flow. The company's product ACCLAIM treats chronic ischemia (lack of oxygen in the heart muscle). Angx1039 is being developed to treat peripheral vascular disease (a narrowing of the vessels carrying blood to the legs, arms and internal organs) and Angx3227 targets sickle cell disease (an inherited disorder that affects the shape of red blood cells). Its fourth product, Vasotrophin increases blood vessel density. The company is headquartered at Burlingame, CA | Health Technology |
INSMED Pharmaceuticals, Inc.
INSMED Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology INSMED Pharmaceuticals, Inc. develops products for the diagnosis and treatment of conditions associated with insulin resistance. The company is headquartered in Richmond, VA. | Health Technology |
Nycomed Pharma Holding A/S
Nycomed Pharma Holding A/S Pharmaceuticals: GenericHealth Technology Nycomed Pharma Holding A/S operates as a holding company with an interest in manufacturing generic drugs. It is active in therapeutic areas, such as cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. The company develops, manufactures, and markets products through Nycomed Pharma A/S. Nycomed Pharma Holding is headquartered in Roskilde, Denmark. | Health Technology |
Affitech AS /Old/
Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Affitech AS discovers and develops human therapeutic antibodies. It focuses on molecule and cell based antibody discovery. The company was founded by Martin Welschof, Ole Jorgen Marvik, and Michael Braunagel in 1997 and is headquartered in Oslo, Norway. | Commercial Services |
Centaur Pharmaceuticals, Inc. | Health Technology |
Engelsen Invest AS
Engelsen Invest AS Financial ConglomeratesFinance Engelsen Invest AS operates as a venture capital firm. It engages in portfolio investment services. The firm provides investment services such as investment trusts. The company was founded on June 15, 2001 and is headquartered in Stabekk, Norway. | Finance |
Holberg EEG AS
Holberg EEG AS Packaged SoftwareTechnology Services Holberg EEG AS develops systematic computer based classification and reporting software. Its products for standardised structural interpretation, reporting and sharing of advanced diagnostic data and is currently focused in the field of electroencephalography. The company was founded by Harald Aurlien and Jan Brgger in 2009 and is headquartered in Bergen, Norway. | Technology Services |
Hafslund Nycomed AS | Health Technology |
Takeda AS
Takeda AS Pharmaceuticals: MajorHealth Technology Takeda AS operates as a pharmaceutical company. It manufactures and distributes generic medicines. The firm offers therapeutics in the areas such as cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. The company founded by Morten Nyegaard in 1874 and is headquartered in Asker, Norway. | Health Technology |
- Börse
- Insiders
- Steinar Johan Engelsen
- Erfahrung